Nutraceutical Ingredients Market
完整報告名稱與涵蓋範圍
Nutraceutical Ingredients Market by Ingredient Type (Functional Proteins, Amino Acids, Probiotics, Others), Application (Human Nutrition, Animal Nutrition), Source (Plant-Based, Animal-Based, Others), Function, and Region - Global Forecast to 2031
報告摘要
The nutraceutical ingredients market is projected to grow from USD 108.33 billion in 2026 to USD 161.53 billion in 2031, at a CAGR of 7.3%.
“Expanding use of amino acids in sports and specialized nutrition is expected to drive market growth”
Amino acids are increasingly incorporated into sports nutrition, dietary supplements, and specialized nutrition products, particularly formulations designed to support muscle recovery, physical performance, and protein intake. Branched-chain amino acids, essential amino acids, non-essential amino acids, and specialty amino acids are used across a range of formulations, with branched-chain amino acids particularly common in sports nutrition products targeting exercise performance and recovery. Their availability in standardized and high-purity forms enables manufacturers to develop products in powders, capsules, tablets, and functional beverages. In addition, advances in fermentation-based production are improving the efficiency, consistency, and scalability of amino acid manufacturing, supporting the availability of ingredients for different formulation requirements. The continued development of sports nutrition, active-aging, and specialized nutrition products is further broadening the use of amino acids across nutraceutical applications.
“Established nutritional and functional benefits of animal-based nutraceutical ingredients to support market growth.”
By source, the animal-based segment accounts for a significant share of the nutraceutical ingredients market, supported by the high nutritional value, bioavailability, and established functional benefits of animal-derived ingredients. Animal-based sources provide a range of high-value nutrients and bioactive compounds used in products targeting joint, bone, muscle, cardiovascular, skin, and cognitive health. Their established use in sports nutrition is further supporting demand, particularly for protein-based products such as protein powders, meal replacements, and recovery beverages. Animal-derived ingredients also have an important role in infant and early-life nutrition, where dairy proteins and specialized components are used in formulations designed to support growth and development. In addition, their use in medical and specialized nutrition is supported by their nutritional quality and established scientific evidence, particularly in products addressing malnutrition, muscle loss, recovery, and age-related nutritional needs. These established applications across sports, infant, medical, and healthy-aging nutrition continue to sustain demand for animal-based nutraceutical ingredients.
“North America is expected to account for a significant share of the nutraceutical ingredients market due to strong consumer demand and an established nutraceutical industry.”
North America is expected to account for a significant share of the nutraceutical ingredients market, supported by strong consumption of dietary supplements, high consumer awareness of preventive healthcare, and growing demand for functional nutrition products. The region has a well-established market for dietary supplements used across immunity, heart health, digestive wellness, sports nutrition, and healthy aging applications. High disposable incomes and healthcare spending support consumer willingness to spend on premium wellness, nutrition, and health products. In addition, the established functional food and beverage market, including protein-fortified foods, probiotic products, functional dairy products, energy and sports drinks, and fortified beverages, creates consistent demand for nutraceutical ingredients. The growing aging population is further increasing demand for products supporting joint, bone, cognitive, cardiovascular, and healthy aging needs, while the strong sports and active nutrition industry supports the use of protein ingredients, amino acids, and functional nutrition ingredients.
In-depth interviews were conducted with chief executive officers (CEOs), directors, and managers from various key organizations operating in the nutraceutical ingredients market.
• By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30%
• By Designation: Directors– 35%, C-level – 40%, Others – 25%
• By Region: North America – 20%, Europe – 25%, Asia Pacific – 35%, South America – 15%, and Rest of the World –5%
Prominent companies in the nutraceutical ingredients market include Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Glanbia PLC (Ireland), Arla Foods amba (Denmark), dsm-firmenich (Netherlands), Ingredion Incorporated (US), Tate & Lyle PLC (UK), Roquette Frères (France), Associated British Foods PLC (UK), Fonterra Co-operative Group Limited (New Zealand), Kerry Group PLC (Ireland), Novonesis Group (Denmark), Balchem Corporation (US), Ajinomoto Co., Inc. (Japan), Divi's Laboratories Limited (India), Kemin Industries (US), GELITA AG (Germany), BENEO GmbH (Germany), Cosucra Groupe Warcoing SA (Belgium), Conagen Inc. (US), Sarshika Pharmachem LLP (India), Canurta Naturals USA (US), and EVANIUM (US).
Research Coverage
This research report categorizes the nutraceutical ingredients market, by ingredient type (functional proteins, omega-3 fatty acids, probiotics, prebiotics, fibers & specialty carbohydrates, vitamins [vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, and others], minerals [calcium, magnesium, iron, zinc, other minerals], amino acids [branched-chain amino acids, essential amino acids, non-essential amino acids, specialty amino acids], carotenoids, other types), source (plant-based, animal-based, microbial-based, synthetics), function (nutritional support, digestive health, immune health, cardiovascular health, bone & joint health, cognitive & mental health, sports & performance, weight management, others), and application (human nutrition [dietary supplements, functional foods, functional beverages, medical & specialized nutrition, infant & early-life nutrition], animal nutrition [companion animal nutrition, livestock nutrition, aquaculture nutrition, other animal nutrition]), and region (North America, Europe, Asia Pacific, South America, RoW).
The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the nutraceutical ingredients industry. A thorough analysis of the key industry players was done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the nutraceutical ingredients market. This report provides a competitive analysis of emerging startups in the nutraceutical ingredients market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.
Reasons to Buy This Report
The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall nutraceutical ingredients and their subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
• Analysis of key drivers (increasing adoption of dietary supplements and targeted health products, Growing demand for fortified and functionally enhanced foods and beverages), restraints (higher costs associated with fortification and functional formulation, stringent regulatory requirements and health-claim restrictions), opportunities (widespread micronutrient deficiencies and continued use of fortification and supplementation, growing demand for preventive and healthy aging nutrition), and challenges (advancements in delivery technologies enhancing bioavailability and stability of nutraceutical ingredients, variability and quality-control challenges for botanical and natural ingredients)
• Product Development/Innovation: Detailed insights into research & development activities and new product launches in the nutraceutical ingredients market
• Market Development: Comprehensive information about lucrative markets, by offering analysis of nutraceutical ingredients across varied regions
• Market Diversification: Exhaustive information about product sources, geographies, recent developments, and investments in the nutraceutical ingredients market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Glanbia PLC (Ireland), Arla Foods amba (Denmark), dsm-firmenich (Netherlands), Ingredion Incorporated (US), Tate & Lyle PLC (UK), Roquette Frères (France), Associated British Foods PLC (UK), Fonterra Co-operative Group Limited (New Zealand), Kerry Group PLC (Ireland), Novonesis Group (Denmark), Balchem Corporation (US) and other players in the nutraceutical ingredients market
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
目錄 Table of Contents
1 INTRODUCTION 47
1.1 STUDY OBJECTIVES 47
1.2 MARKET DEFINITION 47
1.3 STUDY SCOPE 48
1.3.1 INCLUSIONS AND EXCLUSIONS 49
1.3.2 YEARS CONSIDERED 50
1.4 CURRENCY CONSIDERED 51
1.5 UNIT CONSIDERED 51
1.6 STAKEHOLDERS 52
1.7 SUMMARY OF CHANGES 53
2 EXECUTIVE SUMMARY 54
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 54
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 55
2.3 DISRUPTIVE TRENDS IN NUTRACEUTICAL INGREDIENTS MARKET 56
2.4 HIGH-GROWTH SEGMENTS 57
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 58
3 PREMIUM INSIGHTS 59
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET 59
3.2 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE AND REGION 60
3.3 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE 61
3.4 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE 62
3.5 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 62
3.6 NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY 63
4 MARKET OVERVIEW 64
4.1 INTRODUCTION 64
4.2 MARKET DYNAMICS 65
4.2.1 DRIVERS 66
4.2.1.1 Increasing adoption of dietary supplements and targeted health products 66
4.2.1.2 Growing demand for fortified and functionally enhanced foods and beverages 66
4.2.1.3 Rising incidence of chronic diseases 67
4.2.2 RESTRAINTS 68
4.2.2.1 High Cost and price volatility of nutraceutical ingredients 68
4.2.2.2 Stringent regulatory requirements and health-claim restrictions 69
4.2.3 OPPORTUNITIES 69
4.2.3.1 Widespread micronutrient deficiencies and continued use of fortification and supplementation 69
4.2.3.2 Growing demand for preventive and healthy aging nutrition 70
4.2.3.3 Advancements in delivery technologies enhancing bioavailability and stability of nutraceutical ingredients 70
4.2.4 CHALLENGES 71
4.2.4.1 Variability and quality-control challenges for botanical and natural ingredients 71
4.2.4.2 Supply chain disruptions and availability of nutraceutical raw materials 72
4.3 UNMET NEEDS AND WHITE SPACES 73
4.3.1 UNMET NEEDS IN NUTRACEUTICAL INGREDIENTS MARKET 73
4.3.2 WHITE SPACE OPPORTUNITIES 75
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 78
4.4.1 INTERCONNECTED MARKETS 78
4.4.2 CROSS-SECTOR OPPORTUNITIES 79
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 81
4.5.1 KEY MOVES AND STRATEGIC FOCUS 81
5 INDUSTRY TRENDS 84
5.1 INTRODUCTION 84
5.2 PORTER’S FIVE FORCES ANALYSIS 85
5.2.1 THREAT OF NEW ENTRANTS 86
5.2.2 THREAT OF SUBSTITUTES 87
5.2.3 BARGAINING POWER OF SUPPLIERS 87
5.2.4 BARGAINING POWER OF BUYERS 88
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 89
5.3 MACROECONOMIC INDICATORS 89
5.3.1 GLOBAL HEALTHCARE EXPENDITURE 89
5.3.2 REAL HOUSEHOLD INCOME 91
5.4 VALUE CHAIN ANALYSIS 92
5.4.1 RAW MATERIAL SOURCING 92
5.4.2 EXTRACTION & PROCESSING 93
5.4.3 INGREDIENT MANUFACTURING & STANDARDIZATION 93
5.4.4 QUALITY ASSURANCE, R&D & REGULATORY 93
5.4.5 COMMERCIALIZATION & DISTRIBUTION 93
5.4.6 INGREDIENT APPLICATION 93
5.5 ECOSYSTEM ANALYSIS 94
5.5.1 DEMAND SIDE 94
5.5.2 SUPPLY SIDE 94
5.6 PRICING ANALYSIS 96
5.6.1 INDICATIVE PRICE TREND AMONG MARKET PLAYERS 96
5.6.2 AVERAGE SELLING PRICE TREND, BY INGREDIENT TYPE 97
5.6.3 AVERAGE SELLING PRICE TREND, BY REGION 98
5.7 TRADE ANALYSIS 99
5.7.1 TRADE ANALYSIS OF HS CODE 2936: PROVITAMINS AND VITAMINS 100
5.7.1.1 Export Trends of HS Code 2936 (2021–2025) 100
5.7.1.2 Import Trends under HS Code 2936 (2021–2025) 101
5.8 KEY CONFERENCES & EVENTS 104
5.9 TRENDS IMPACTING CUSTOMERS’ BUSINESSES 105
5.10 INVESTMENT AND FUNDING SCENARIO 106
5.11 CASE STUDY ANALYSIS 107
5.11.1 DSM-FIRMENICH SUPPORTED KOREA EUNDAN’S TRANSITION TO ALGAL OMEGA-3 107
5.11.2 KERRY – BC30 PROBIOTIC IN FUNCTIONAL HOT BEVERAGE 107
5.11.3 INGREDION – VITESSENCE PULSE 1853 PEA PROTEIN IN VEGAN BEVERAGE 108
5.12 IMPACT OF US TARIFF – NUTRACEUTICAL INGREDIENTS MARKET 108
5.12.1 INTRODUCTION 108
5.12.2 PRICE IMPACT ANALYSIS 109
5.12.3 IMPACT ON COUNTRY/REGION 110
5.12.3.1 US 110
5.12.3.2 Europe 110
5.12.3.3 Asia Pacific 110
5.12.4 IMPACT ON END-USE INDUSTRIES 110
6 REGULATORY AND SUSTAINABILITY LANDSCAPE 112
6.1 INTRODUCTION 112
6.2 REGIONAL REGULATIONS AND COMPLIANCE 112
6.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
6.2.2 INDUSTRY STANDARDS 118
6.3 SUSTAINABILITY INITIATIVES 119
6.3.1 SUSTAINABLE AND RESPONSIBLE SOURCING 120
6.3.2 RESOURCE EFFICIENCY AND LOW-CARBON MANUFACTURING 121
6.3.3 CIRCULAR ECONOMY AND SUSTAINABLE PRODUCTION 121
6.3.4 CIRCULAR ECONOMY AND FOOD WASTE REDUCTION 122
6.4 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 123
6.5 CERTIFICATIONS, LABELING, ECO-STANDARDS 125
7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 129
7.1 INTRODUCTION 129
7.2 KEY TECHNOLOGIES 129
7.2.1 ADVANCED EXTRACTION & PURIFICATION TECHNOLOGIES 129
7.2.2 PRECISION FERMENTATION & ADVANCED BIOPROCESSING 130
7.2.3 ENCAPSULATION & ADVANCED DELIVERY SYSTEMS 130
7.3 COMPLEMENTARY TECHNOLOGIES 130
7.3.1 ADVANCED ANALYTICAL & CHARACTERIZATION TECHNOLOGIES 130
7.3.2 NANOTECHNOLOGY & ADVANCED FORMULATION TECHNOLOGIES 131
7.3.3 AUTOMATION, PROCESS MONITORING & DIGITAL MANUFACTURING TECHNOLOGIES 131
7.4 ADJACENT TECHNOLOGIES 131
7.4.1 SYNTHETIC BIOLOGY & BIOINFORMATICS 131
7.4.2 PERSONALIZED NUTRITION & DIGITAL HEALTH TECHNOLOGIES 132
7.4.3 ADVANCED FOOD PROCESSING & 3D FOOD-PRINTING TECHNOLOGIES 132
7.5 TECHNOLOGY/PRODUCT ROADMAP 132
7.5.1 SHORT-TERM | OPTIMIZATION OF EXTRUSION PROCESSES AND CLEAN-LABEL PRODUCT DEVELOPMENT 132
7.5.2 MID-TERM | INTELLIGENT MANUFACTURING AND COMMERCIALIZATION OF NEXT-GENERATION PROTEIN INGREDIENTS 133
7.5.3 LONG-TERM | AUTONOMOUS AI-DRIVEN MANUFACTURING AND SUSTAINABLE PROTEIN INNOVATION 133
7.6 PATENT ANALYSIS 133
7.6.1 LIST OF MAJOR PATENTS 135
7.7 FUTURE APPLICATIONS 135
7.7.1 PERSONALIZED & PRECISION NUTRITION 136
7.7.2 FUNCTIONAL & SPECIALIZED NUTRITION PRODUCTS 137
7.8 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL INGREDIENTS MARKET 137
7.8.1 INTRODUCTION 137
7.8.2 TOP USE CASES AND MARKET POTENTIAL 138
7.8.3 BEST PRACTICES IN NUTRACEUTICAL INGREDIENTS INDUSTRY 138
7.8.4 CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL INGREDIENTS MARKET 139
7.8.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 140
7.8.6 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NUTRACEUTICAL INGREDIENTS MARKET 141
7.9 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 141
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 142
8.1 INTRODUCTION 142
8.2 DECISION-MAKING PROCESS 142
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 144
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 144
8.3.2 BUYING CRITERIA 146
8.4 ADOPTION BARRIERS AND INTERNAL CHALLENGES 148
8.5 UNMET NEEDS OF VARIOUS END-USE INDUSTRIES 149
8.6 MARKET PROFITABILITY 151
9 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTION 152
9.1 INTRODUCTION 152
9.2 NUTRITIONAL SUPPORT 153
9.3 DIGESTIVE HEALTH 153
9.4 IMMUNE HEALTH 154
9.5 CARDIOVASCULAR HEALTH 154
9.6 BONE & JOINT HEALTH 155
9.7 COGNITIVE & MENTAL HEALTH 156
9.8 SPORTS & PERFORMANCE 156
9.9 WEIGHT MANAGEMENT 157
9.10 OTHERS (BEAUTY & HEALTHY AGING, ETC.) 157
10 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE 158
10.1 INTRODUCTION 159
10.2 FUNCTIONAL PROTEINS 162
10.2.1 NUTRITIONAL FUNCTIONALITY AND EXPANDING APPLICATIONS 162
10.3 OMEGA-3 FATTY ACIDS 164
10.3.1 GROWING DEMAND FOR CARDIOVASCULAR, COGNITIVE, AND PREVENTIVE NUTRITION 164
10.4 PROBIOTICS 166
10.4.1 EXPANDING APPLICATIONS IN GUT HEALTH AND FUNCTIONAL NUTRITION 166
10.5 PREBIOTICS 168
10.5.1 SUPPORTING GUT MICROBIOME HEALTH AND FUNCTIONAL NUTRITION 168
10.6 FIBERS & SPECIALTY CARBOHYDRATES 170
10.6.1 EXPANDING ROLE IN DIGESTIVE HEALTH AND PRODUCT FORMULATION 170
10.7 VITAMINS 172
10.7.1 ESSENTIAL MICRONUTRIENTS SUPPORTING PREVENTIVE AND SPECIALIZED NUTRITION 172
10.7.2 VITAMIN A 174
10.7.3 VITAMIN B 175
10.7.4 VITAMIN C 176
10.7.5 VITAMIN D 177
10.7.6 VITAMIN E 178
10.7.7 OTHER VITAMINS (MULTIVITAMIN, ETC.) 179
10.8 MINERALS 180
10.8.1 ESSENTIAL MICRONUTRIENTS ACROSS SUPPLEMENTATION, FORTIFICATION, AND SPECIALIZED NUTRITION 180
10.8.2 CALCIUM 183
10.8.3 MAGNESIUM 184
10.8.4 IRON 185
10.8.5 ZINC 186
10.8.6 OTHER MINERALS 187
10.9 AMINO ACIDS 188
10.9.1 EXPANDING ROLE IN TARGETED NUTRITION, SPORTS PERFORMANCE, AND METABOLIC SUPPORT 188
10.9.2 BRANCHED-CHAIN AMINO ACIDS 191
10.9.3 ESSENTIAL AMINO ACIDS 192
10.9.4 NON-ESSENTIAL AMINO ACIDS 193
10.9.5 SPECIALTY AMINO ACIDS 194
10.10 CAROTENOIDS 195
10.10.1 NATURAL PIGMENTS WITH EXPANDING NUTRITIONAL AND FUNCTIONAL APPLICATIONS 195
10.11 OTHER INGREDIENT TYPES 197
11 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE 200
11.1 INTRODUCTION 201
11.2 PLANT-BASED 202
11.2.1 EXPANSION OF PLANT-BASED SUPPLY AND PROCESSING CAPACITY TO DRIVE NUTRACEUTICAL INGREDIENT MARKET GROWTH 202
11.3 ANIMAL-BASED 204
11.3.1 GROWING DEMAND FOR HIGH-PROTEIN AND BIOACTIVE INGREDIENTS TO DRIVE ANIMAL-BASED INGREDIENT GROWTH 204
11.4 MICROBIAL-BASED 205
11.4.1 EXPANSION OF MICROBIAL-DERIVED INGREDIENTS AND FERMENTATION-BASED PRODUCTION TO DRIVE MARKET GROWTH 205
11.5 SYNTHETICS 207
11.5.1 CONSISTENT QUALITY AND SCALABLE PRODUCTION OF SYNTHETIC INGREDIENTS TO SUPPORT MARKET GROWTH 207
12 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 209
12.1 INTRODUCTION 210
12.2 HUMAN NUTRITION 212
12.2.1 DIETARY SUPPLEMENTS 213
12.2.1.1 Dietary supplements remain largest application for nutraceutical ingredients due to their established consumer acceptance 213
12.2.2 FUNCTIONAL FOODS 214
12.2.2.1 Growing health-conscious consumption is driving nutraceutical ingredient adoption in functional foods 214
12.2.3 FUNCTIONAL BEVERAGES 215
12.2.3.1 Demand for convenient wellness products is accelerating nutraceutical ingredient use in beverages 215
12.2.4 MEDICAL & SPECIALIZED NUTRITION 216
12.2.4.1 Rising demand for targeted nutrition is supporting use of specialty nutraceutical ingredients 216
12.2.5 INFANT & EARLY-LIFE NUTRITION 217
12.2.5.1 Greater focus on early-life health is driving demand for high-quality nutraceutical ingredients 217
12.3 ANIMAL NUTRITION 218
12.3.1 COMPANION ANIMAL NUTRITION 220
12.3.1.1 Pet humanization is accelerating demand for nutraceutical ingredients in companion animal nutrition 220
12.3.2 LIVESTOCK NUTRITION 221
12.3.2.1 Reduced reliance on antibiotics is driving nutraceutical adoption in livestock nutrition 221
12.3.3 AQUACULTURE NUTRITION 222
12.3.3.1 Growing aquaculture production is increasing demand for functional nutrition ingredients 222
12.3.4 OTHER ANIMAL NUTRITION 223
12.3.4.1 Specialized animal health needs are creating demand for targeted nutraceutical ingredients 223
13 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 225
13.1 INTRODUCTION 226
13.2 NORTH AMERICA 229
13.2.1 US 238
13.2.1.1 Strong supplement penetration and rising demand for functional nutrition 238
13.2.2 CANADA 245
13.2.2.1 Growing demand for natural products supports market expansion 245
13.2.3 MEXICO 251
13.2.3.1 Expanding preventive nutrition demand and broadening supplement ecosystem 251
13.3 EUROPE 258
13.3.1 GERMANY 266
13.3.1.1 High food supplement penetration and demand for micronutrients support market growth 266
13.3.2 UK 273
13.3.2.1 Established food supplement use and regulatory support for innovative ingredients support market growth 273
13.3.3 FRANCE 279
13.3.3.1 Established supplement market and growing demand for targeted nutrition support market growth 279
13.3.4 ITALY 286
13.3.4.1 Large supplement product base and broad use of nutritional ingredients support market growth 286
13.3.5 SPAIN 292
13.3.5.1 Established supplement regulation and broad nutritional ingredient applications support market growth 292
13.3.6 REST OF EUROPE 298
13.3.6.1 Expanding food supplement use and regulatory harmonization support market opportunities 298
13.4 ASIA PACIFIC 305
13.4.1 CHINA 314
13.4.1.1 Expanding health food formulation and diversification of nutritional products support market growth 314
13.4.2 INDIA 321
13.4.2.1 Large agricultural base and expanding nutraceutical ecosystem support market growth 321
13.4.3 JAPAN 328
13.4.3.1 Rapid population aging and preventive healthcare culture drive demand for functional ingredients 328
13.4.4 AUSTRALIA & NEW ZEALAND 335
13.4.4.1 Strong supplement adoption and export-oriented health product ecosystem support nutraceutical ingredient demand 335
13.4.5 REST OF ASIA PACIFIC 342
13.5 SOUTH AMERICA 348
13.5.1 BRAZIL 357
13.5.1.1 Strong supplement penetration and rapid expansion of protein and vitamin ingredients 357
13.5.2 ARGENTINA 364
13.5.2.1 Growing demand for targeted nutrition and specialty nutraceutical ingredients 364
13.5.3 REST OF SOUTH AMERICA 370
13.5.3.1 Emerging consumer awareness and diversification of functional nutrition 370
13.6 REST OF THE WORLD (ROW) 377
13.6.1 MIDDLE EAST 385
13.6.1.1 Rising nutrition-related health needs and preventive healthcare focus 385
13.6.2 AFRICA 391
13.6.2.1 Nutritional needs and food fortification programs create structural ingredient demand 391
14 COMPETITIVE LANDSCAPE 398
14.1 OVERVIEW 398
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2026 399
14.3 BRAND/PRODUCT COMPARISON 401
14.3.1 CARGILL, INCORPORATED (EPICOR) 402
14.3.2 ADM (FIBERSOL) 402
14.3.3 GLANBIA PLC (FERRIUP) 402
14.3.4 DSM-FIRMENICH (PEPTOPRO) 402
14.3.5 ROQUETTE FRÈRES (NUTRALYS) 402
14.4 REVENUE ANALYSIS, 2023–2025 402
14.5 COMPANY VALUATION AND FINANCIAL METRICS 404
14.5.1 COMPANY VALUATION 404
14.5.2 EV/EBITDA 405
14.6 MARKET SHARE ANALYSIS, 2025 405
14.7 NUTRACEUTICAL INGREDIENTS MARKET COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 407
14.7.1 STARS 408
14.7.2 EMERGING LEADERS 408
14.7.3 PERVASIVE PLAYERS 408
14.7.4 PARTICIPANTS 408
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 410
14.7.5.1 Company footprint 410
14.7.5.2 Region footprint 410
14.7.5.3 Ingredient type footprint 411
14.7.5.4 Source footprint 412
14.7.5.5 Application footprint 413
14.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2025 414
14.8.1 PROGRESSIVE COMPANIES 414
14.8.2 RESPONSIVE COMPANIES 414
14.8.3 DYNAMIC COMPANIES 414
14.8.4 STARTING BLOCKS 414
14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 416
14.8.5.1 Key startups/SMEs 416
14.8.5.2 Competitive benchmarking of key startups/SMEs 417
14.9 COMPETITIVE SCENARIO 418
14.9.1 PRODUCT LAUNCHES 418
14.9.2 DEALS 420
14.9.3 EXPANSIONS 422
15 COMPANY PROFILES 425
15.1 KEY PLAYERS 425
15.1.1 CARGILL, INCORPORATED 425
15.1.1.1 Business overview 425
15.1.1.2 Products offered 426
15.1.1.3 Recent developments 429
15.1.1.3.1 Product launches 429
15.1.1.3.2 Deals 430
15.1.1.3.3 Expansions 431
15.1.1.3.4 Other developments 433
15.1.1.4 MnM view 434
15.1.1.4.1 Right to win 434
15.1.1.4.2 Strategic choices 434
15.1.1.4.3 Weaknesses and competitive threats 434
15.1.2 ADM 435
15.1.2.1 Business overview 435
15.1.2.2 Products offered 436
15.1.2.3 Recent developments 441
15.1.2.3.1 Product launches 441
15.1.2.3.2 Deals 441
15.1.2.3.3 Expansions 443
15.1.2.3.4 Other developments 444
15.1.2.4 MnM view 445
15.1.2.4.1 Right to win 445
15.1.2.4.2 Strategic choices 446
15.1.2.4.3 Weaknesses and competitive threats 446
15.1.3 INTERNATIONAL FLAVORS & FRAGRANCES INC. 447
15.1.3.1 Business overview 447
15.1.3.2 Products offered 448
15.1.3.3 Recent developments 451
15.1.3.3.1 Product launches 451
15.1.3.3.2 Deals 453
15.1.3.3.3 Expansions 454
15.1.3.3.4 Other developments 456
15.1.3.4 MnM view 456
15.1.3.4.1 Right to win 456
15.1.3.4.2 Strategic choices 457
15.1.3.4.3 Weaknesses and competitive threats 457
15.1.4 BASF 458
15.1.4.1 Business overview 458
15.1.4.2 Products offered 459
15.1.4.3 Recent developments 463
15.1.4.3.1 Product launches 463
15.1.4.3.2 Deals 463
15.1.4.3.3 Expansions 464
15.1.4.3.4 Other developments 465
15.1.4.4 MnM view 466
15.1.4.4.1 Right to win 466
15.1.4.4.2 Strategic choices 466
15.1.4.4.3 Weaknesses and competitive threats 466
15.1.5 GLANBIA PLC 467
15.1.5.1 Business overview 467
15.1.5.2 Products offered 468
15.1.5.3 Recent developments 472
15.1.5.3.1 Product launches 472
15.1.5.3.2 Deals 473
15.1.5.3.3 Expansions 474
15.1.5.3.4 Other developments 475
15.1.5.4 MnM view 475
15.1.5.4.1 Right to win 475
15.1.5.4.2 Strategic choices 476
15.1.5.4.3 Weaknesses and competitive threats 476
15.1.6 ARLA FOODS AMBA 477
15.1.6.1 Business overview 477
15.1.6.2 Products offered 478
15.1.6.3 Recent developments 480
15.1.6.3.1 Product launches 480
15.1.6.3.2 Deals 481
15.1.6.3.3 Expansions 483
15.1.6.3.4 Other developments 484
15.1.6.4 MnM view 485
15.1.7 DSM-FIRMENICH 486
15.1.7.1 Business overview 486
15.1.7.2 Products offered 487
15.1.7.3 Recent developments 494
15.1.7.3.1 Product launches 494
15.1.7.3.2 Deals 496
15.1.7.3.3 Expansions 497
15.1.7.3.4 Other developments 499
15.1.7.4 MnM view 500
15.1.8 INGREDION 501
15.1.8.1 Business overview 501
15.1.8.2 Products offered 502
15.1.8.3 Recent developments 505
15.1.8.3.1 Product launches 505
15.1.8.3.2 Deals 507
15.1.8.3.3 Expansions 508
15.1.8.3.4 Other developments 508
15.1.8.4 MnM view 509
15.1.9 TATE & LYLE 510
15.1.9.1 Business overview 510
15.1.9.2 Recent developments 512
15.1.9.2.1 Product launches 512
15.1.9.2.2 Deals 513
15.1.9.2.3 Expansions 514
15.1.9.2.4 Other developments 515
15.1.9.3 MnM view 515
15.1.10 ROQUETTE FRÈRES 516
15.1.10.1 Business overview 516
15.1.10.2 Products offered 517
15.1.10.3 Recent developments 520
15.1.10.3.1 Product launches 520
15.1.10.3.2 Deals 521
15.1.10.3.3 Expansions 522
15.1.10.3.4 Other developments 522
15.1.10.4 MnM view 523
15.1.11 ASSOCIATED BRITISH FOODS PLC 524
15.1.11.1 Business overview 524
15.1.11.2 Products offered 525
15.1.11.3 Recent developments 528
15.1.11.3.1 Product launches 528
15.1.11.3.2 Deals 529
15.1.11.3.3 Expansions 530
15.1.11.3.4 Other developments 531
15.1.11.4 MnM view 531
15.1.12 FONTERRA CO-OPERATIVE GROUP LIMITED 533
15.1.12.1 Business overview 533
15.1.12.2 Products offered 534
15.1.12.3 Recent developments 538
15.1.12.3.1 Product launches 538
15.1.12.3.2 Deals 538
15.1.12.3.3 Expansions 539
15.1.12.3.4 Other developments 540
15.1.12.4 MnM view 540
15.1.13 KERRY GROUP PLC 541
15.1.13.1 Business overview 541
15.1.13.2 Products offered 542
15.1.13.3 Recent developments 546
15.1.13.3.1 Product launches 546
15.1.13.3.2 Deals 546
15.1.13.3.3 Expansions 548
15.1.13.3.4 Other developments 548
15.1.13.4 MnM view 549
15.1.14 NOVONESIS GROUP 550
15.1.14.1 Business overview 550
15.1.14.2 Products offered 551
15.1.14.3 Recent developments 554
15.1.14.3.1 Product launches 554
15.1.14.3.2 Deals 555
15.1.14.3.3 Expansions 555
15.1.14.3.4 Other developments 556
15.1.14.4 MnM view 557
15.1.15 BALCHEM CORP. 558
15.1.15.1 Business overview 558
15.1.15.2 Products offered 559
15.1.15.3 Recent developments 563
15.1.15.3.1 Product launches 563
15.1.15.3.2 Deals 564
15.1.15.3.3 Expansions 565
15.1.15.3.4 Other developments 566
15.1.15.4 MnM view 567
15.2 OTHER PLAYERS 568
15.2.1 AJINOMOTO CO., INC. 568
15.2.1.1 Business overview 568
15.2.1.2 Products offered 569
15.2.1.3 Recent developments 571
15.2.1.3.1 Deals 571
15.2.1.3.2 Expansions 572
15.2.1.3.3 Other developments 572
15.2.1.4 MnM view 573
15.2.2 DIVI'S LABORATORIES LIMITED 574
15.2.2.1 Business overview 574
15.2.2.2 Products offered 575
15.2.2.3 Recent developments 578
15.2.2.3.1 Deals 578
15.2.2.3.2 Expansions 578
15.2.2.4 MnM view 579
15.2.3 KEMIN INDUSTRIES, INC. 580
15.2.3.1 Business overview 580
15.2.3.2 Products offered 581
15.2.3.3 Recent developments 582
15.2.3.3.1 Product launches 582
15.2.3.3.2 Deals 583
15.2.3.3.3 Other developments 584
15.2.3.4 MnM view 584
15.2.4 GELITA 585
15.2.4.1 Business overview 585
15.2.4.2 Products offered 585
15.2.4.3 Recent developments 587
15.2.4.3.1 Product launches 587
15.2.4.3.2 Deals 588
15.2.4.3.3 Expansions 588
15.2.4.3.4 Other developments 589
15.2.4.4 MnM view 589
15.2.5 BENEO 590
15.2.5.1 Business overview 590
15.2.5.2 Products offered 591
15.2.5.3 Recent developments 592
15.2.5.3.1 Product launches 592
15.2.5.3.2 Deals 593
15.2.5.3.3 Expansions 594
15.2.5.3.4 Other developments 595
15.2.5.4 MnM view 595
15.2.6 COSUCRA 596
15.2.7 CONAGEN, INC. 597
15.2.8 SARSHIKA PHARMACHEM LLP 598
15.2.9 CANURTA NATURALS USA 599
15.2.10 EVANIUM 600
16 RESEARCH METHODOLOGY 601
16.1 RESEARCH DATA 601
16.1.1 SECONDARY DATA 602
16.1.1.1 List of major secondary sources 602
16.1.1.2 Key data from secondary sources 602
16.1.2 PRIMARY DATA 603
16.1.2.1 Key data from primary sources 603
16.1.2.2 Key industry insights 604
16.1.2.3 Breakdown of primaries 604
16.2 MARKET SIZE ESTIMATION 605
16.2.1 BOTTOM-UP APPROACH 605
16.2.2 TOP-DOWN APPROACH 607
16.2.2.1 Approach to estimate market size using top-down analysis 607
16.2.3 SUPPLY-SIDE ANALYSIS 608
16.2.4 DEMAND-SIDE ANALYSIS 608
16.3 DATA TRIANGULATION 610
16.4 RESEARCH ASSUMPTIONS 611
16.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 611
17 ADJACENT & RELATED MARKETS 612
17.1 INTRODUCTION 612
17.2 LIMITATIONS 612
17.3 PROTEIN INGREDIENTS MARKET 613
17.3.1 MARKET DEFINITION 613
17.3.2 MARKET OVERVIEW 613
17.4 NUTRACEUTICAL GUMMIES MARKET 615
17.4.1 MARKET DEFINITION 615
17.4.2 MARKET OVERVIEW 615
18 APPENDIX 617
18.1 DISCUSSION GUIDE 617
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 622
18.3 CUSTOMIZATION OPTIONS 624
18.4 RELATED REPORTS 624
18.5 AUTHOR DETAILS 625
圖表清單 List of Tables & Figures
TABLE 1 USD EXCHANGE RATES, 2021–2025 51
TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 85
TABLE 3 NUTRACEUTICAL INGREDIENTS MARKET: SUPPLY CHAIN (ECOSYSTEM) 95
TABLE 4 AVERAGE SELLING PRICE (ASP), BY INGREDIENT TYPE, 2022–2025 (USD/KG) 97
TABLE 5 AVERAGE SELLING PRICE (ASP), BY REGION, 2022–2025 (USD/KG) 99
TABLE 6 TOP 10 EXPORTERS OF HS CODE 2936, 2021–2025 (USD MILLION) 102
TABLE 7 TOP 10 EXPORTERS OF HS CODE 2936, 2021–2025 (K TONS) 103
TABLE 8 TOP 10 EXPORTERS OF HS CODE 2936, 2021–2025 (USD MILLION) 103
TABLE 9 TOP 10 IMPORTERS OF HS CODE 2936, 2021–2025 (K TONS) 104
TABLE 10 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2026–2027 104
TABLE 11 TARIFF IMPACT ON END-USE INDUSTRIES: NUTRACEUTICAL INGREDIENTS MARKET 111
TABLE 16 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 117
TABLE 17 GLOBAL INDUSTRY STANDARDS IN NUTRACEUTICAL INGREDIENTS MARKET 119
TABLE 18 SUSTAINABILITY INITIATIVES IN NUTRACEUTICAL INGREDIENTS MARKET 122
TABLE 19 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 123
TABLE 20 CERTIFICATION FOR NUTRACEUTICAL INGREDIENTS MARKET 125
TABLE 21 LABELING FOR NUTRACEUTICAL INGREDIENTS MARKET 126
TABLE 22 ECO-STANDARDS FOR NUTRACEUTICAL INGREDIENTS MARKET 127
TABLE 23 LIST OF MAJOR PATENTS IN NUTRACEUTICAL INGREDIENTS MARKET, 2021–2026 135
TABLE 24 TOP USE CASES AND MARKET POTENTIAL 138
TABLE 25 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 138
TABLE 26 NUTRACEUTICAL INGREDIENTS MARKET: CASE STUDIES RELATED TO
GEN AI IMPLEMENTATION 139
TABLE 27 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 140
TABLE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION 146
TABLE 29 KEY BUYING CRITERIA, BY APPLICATION 148
TABLE 30 UNMET NEEDS IN NUTRACEUTICAL INGREDIENTS MARKET, BY END-USE INDUSTRY 150
TABLE 31 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 160
TABLE 32 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 160
TABLE 33 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 161
TABLE 34 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 161
TABLE 35 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 162
TABLE 36 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 163
TABLE 37 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 163
TABLE 38 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 163
TABLE 39 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 164
TABLE 40 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 165
TABLE 41 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 165
TABLE 42 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 165
TABLE 43 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 166
TABLE 44 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 167
TABLE 45 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (TONS) 167
TABLE 46 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (TONS) 167
TABLE 47 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 168
TABLE 48 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 169
TABLE 49 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (TONS) 169
TABLE 50 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (TONS) 169
TABLE 51 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 170
TABLE 52 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 171
TABLE 53 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 171
TABLE 54 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 171
TABLE 55 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 172
TABLE 56 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 173
TABLE 57 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (TONS) 173
TABLE 58 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (TONS) 173
TABLE 59 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE,
2022–2025 (USD MILLION) 174
TABLE 60 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE,
2026–2031 (USD MILLION) 174
TABLE 61 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 175
TABLE 62 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 175
TABLE 63 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 176
TABLE 64 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 176
TABLE 65 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 177
TABLE 66 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 177
TABLE 67 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 178
TABLE 68 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 178
TABLE 69 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 179
TABLE 70 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 179
TABLE 71 OTHER VITAMINS (MULTIVITAMIN, ETC.): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 180
TABLE 72 OTHER VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 180
TABLE 73 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 181
TABLE 74 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 181
TABLE 75 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (TONS) 182
TABLE 76 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (TONS) 182
TABLE 77 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE,
2022–2025 (USD MILLION) 182
TABLE 78 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE,
2026–2031 (USD MILLION) 183
TABLE 79 CALCIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 184
TABLE 80 CALCIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 184
TABLE 81 MAGNESIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 185
TABLE 82 MAGNESIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 185
TABLE 83 IRON: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 186
TABLE 84 IRON: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 186
TABLE 85 ZINC: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 187
TABLE 86 ZINC: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 187
TABLE 87 OTHER MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 188
TABLE 88 OTHER MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 188
TABLE 89 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 189
TABLE 90 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 189
TABLE 91 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (TONS) 190
TABLE 92 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (TONS) 190
TABLE 93 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE,
2022–2025 (USD MILLION) 190
TABLE 94 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE,
2026–2031 (USD MILLION) 191
TABLE 95 BRANCHED-CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2022–2025 (USD MILLION) 191
TABLE 96 BRANCHED-CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 192
TABLE 97 ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 192
TABLE 98 ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 193
TABLE 99 NON-ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2022–2025 (USD MILLION) 194
TABLE 100 NON-ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 194
TABLE 101 SPECIALTY AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 195
TABLE 102 SPECIALTY AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 195
TABLE 103 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 196
TABLE 104 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 196
TABLE 105 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (TONS) 197
TABLE 106 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (TONS) 197
TABLE 107 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 198
TABLE 108 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 198
TABLE 109 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 199
TABLE 110 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 199
TABLE 111 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022–2025 (USD MILLION) 202
TABLE 112 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026–2031 (USD MILLION) 202
TABLE 113 PLANT-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 203
TABLE 114 PLANT-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 203
TABLE 115 ANIMAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 205
TABLE 116 ANIMAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 205
TABLE 117 MICROBIAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 206
TABLE 118 MICROBIAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 207
TABLE 119 SYNTHETICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 208
TABLE 120 SYNTHETICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 208
TABLE 121 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 211
TABLE 122 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 211
TABLE 123 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 212
TABLE 124 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 212
TABLE 125 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE,
2022–2025 (USD MILLION) 213
TABLE 126 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE,
2026–2031 (USD MILLION) 213
TABLE 127 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 214
TABLE 128 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 214
TABLE 129 FUNCTIONAL FOODS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 215
TABLE 130 FUNCTIONAL FOODS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 215
TABLE 131 FUNCTIONAL BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 216
TABLE 132 FUNCTIONAL BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 216
TABLE 133 MEDICAL & SPECIALIZED NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2022–2025 (USD MILLION) 217
TABLE 134 MEDICAL & SPECIALIZED NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 217
TABLE 135 INFANT & EARLY-LIFE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2022–2025 (USD MILLION) 218
TABLE 136 INFANT & EARLY-LIFE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 218
TABLE 137 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 219
TABLE 138 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 219
TABLE 139 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE,
2022–2025 (USD MILLION) 219
TABLE 140 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE,
2026–2031 (USD MILLION) 220
TABLE 141 COMPANION ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2022–2025 (USD MILLION) 220
TABLE 142 COMPANION ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 221
TABLE 143 LIVESTOCK NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 221
TABLE 144 LIVESTOCK NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 222
TABLE 145 AQUACULTURE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 222
TABLE 146 AQUACULTURE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 223
TABLE 147 OTHER ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 223
TABLE 148 OTHER ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 224
TABLE 149 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 227
TABLE 150 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 228
TABLE 151 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 228
TABLE 152 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 228
TABLE 153 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 230
TABLE 154 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 231
TABLE 155 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2022–2025 (TONS) 231
TABLE 156 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2026–2031 (TONS) 231
TABLE 157 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 232
TABLE 158 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 232
TABLE 159 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 233
TABLE 160 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 233
TABLE 161 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 234
TABLE 162 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 234
TABLE 163 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 234
TABLE 164 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 235
TABLE 165 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 235
TABLE 166 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 235
TABLE 167 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE,
2022–2025 (USD MILLION) 236
TABLE 168 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE,
2026–2031 (USD MILLION) 236
TABLE 169 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 236
TABLE 170 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 236
TABLE 171 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 237
TABLE 172 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 237
TABLE 173 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 237
TABLE 174 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 238
TABLE 175 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 239
TABLE 176 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 239
TABLE 177 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 240
TABLE 178 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 240
TABLE 179 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 241
TABLE 180 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 241
TABLE 181 US: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 241
TABLE 182 US: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 242
TABLE 183 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 242
TABLE 184 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 242
TABLE 185 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 243
TABLE 186 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 243
TABLE 187 US: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 243
TABLE 188 US: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 244
TABLE 189 US: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 244
TABLE 190 US: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 244
TABLE 191 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 245
TABLE 192 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 246
TABLE 193 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 246
TABLE 194 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 247
TABLE 195 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 247
TABLE 196 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 248
TABLE 197 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 248
TABLE 198 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 248
TABLE 199 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 249
TABLE 200 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 249
TABLE 201 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 249
TABLE 202 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 249
TABLE 203 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 250
TABLE 204 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 250
TABLE 205 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 250
TABLE 206 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 251
TABLE 207 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 252
TABLE 208 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 252
TABLE 209 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 253
TABLE 210 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 253
TABLE 211 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 254
TABLE 212 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 254
TABLE 213 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 254
TABLE 214 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 255
TABLE 215 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 255
TABLE 216 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 255
TABLE 217 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 256
TABLE 218 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 256
TABLE 219 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 256
TABLE 220 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 257
TABLE 221 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 257
TABLE 222 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 257
TABLE 223 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 258
TABLE 224 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 259
TABLE 225 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2022–2025 (TONS) 259
TABLE 226 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2026–2031 (TONS) 259
TABLE 227 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 260
TABLE 228 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 260
TABLE 229 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 261
TABLE 230 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 261
TABLE 231 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 262
TABLE 232 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 262
TABLE 233 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 262
TABLE 234 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 263
TABLE 235 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 263
TABLE 236 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 263
TABLE 237 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE,
2022–2025 (USD MILLION) 264
TABLE 238 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE,
2026–2031 (USD MILLION) 264
TABLE 239 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 264
TABLE 240 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 264
TABLE 241 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 265
TABLE 242 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 265
TABLE 243 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 265
TABLE 244 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 266
TABLE 245 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 267
TABLE 246 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 267
TABLE 247 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 268
TABLE 248 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 268
TABLE 249 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 269
TABLE 250 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 269
TABLE 251 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 269
TABLE 252 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 270
TABLE 253 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 270
TABLE 254 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 270
TABLE 255 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 271
TABLE 256 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 271
TABLE 257 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 271
TABLE 258 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 272
TABLE 259 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 272
TABLE 260 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 272
TABLE 261 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 273
TABLE 262 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 274
TABLE 263 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 274
TABLE 264 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 275
TABLE 265 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 275
TABLE 266 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 276
TABLE 267 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 276
TABLE 268 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 276
TABLE 269 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 277
TABLE 270 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 277
TABLE 271 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 277
TABLE 272 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 277
TABLE 273 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 278
TABLE 274 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 278
TABLE 275 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 278
TABLE 276 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 279
TABLE 277 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 280
TABLE 278 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 280
TABLE 279 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 281
TABLE 280 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 281
TABLE 281 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 282
TABLE 282 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 282
TABLE 283 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 282
TABLE 284 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 283
TABLE 285 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 283
TABLE 286 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 283
TABLE 287 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 284
TABLE 288 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 284
TABLE 289 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 284
TABLE 290 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 285
TABLE 291 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 285
TABLE 292 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 285
TABLE 293 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 286
TABLE 294 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 287
TABLE 295 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 287
TABLE 296 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 288
TABLE 297 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 288
TABLE 298 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 288
TABLE 299 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 289
TABLE 300 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 289
TABLE 301 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 289
TABLE 302 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 290
TABLE 303 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 290
TABLE 304 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 290
TABLE 305 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 290
TABLE 306 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 291
TABLE 307 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 291
TABLE 308 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 291
TABLE 309 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 292
TABLE 310 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 293
TABLE 311 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 293
TABLE 312 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 294
TABLE 313 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 294
TABLE 314 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 295
TABLE 315 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 295
TABLE 316 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 295
TABLE 317 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 296
TABLE 318 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 296
TABLE 319 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 296
TABLE 320 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 296
TABLE 321 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 297
TABLE 322 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 297
TABLE 323 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 297
TABLE 324 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 298
TABLE 325 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 299
TABLE 326 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 299
TABLE 327 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 300
TABLE 328 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 300
TABLE 329 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 301
TABLE 330 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 301
TABLE 331 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 301
TABLE 332 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 302
TABLE 333 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 302
TABLE 334 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 302
TABLE 335 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 303
TABLE 336 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 303
TABLE 337 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET,
BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 303
TABLE 338 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET,
BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 304
TABLE 339 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET,
BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 304
TABLE 340 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET,
BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 304
TABLE 341 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 306
TABLE 342 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 307
TABLE 343 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2022–2025 (TONS) 307
TABLE 344 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2026–2031 (TONS) 307
TABLE 345 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 308
TABLE 346 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 308
TABLE 347 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 309
TABLE 348 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 309
TABLE 349 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 310
TABLE 350 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 310
TABLE 351 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 310
TABLE 352 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 311
TABLE 353 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 311
TABLE 354 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 311
TABLE 355 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE,
2022–2025 (USD MILLION) 312
TABLE 356 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE,
2026–2031 (USD MILLION) 312
TABLE 357 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 312
TABLE 358 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 312
TABLE 359 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 313
TABLE 360 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 313
TABLE 361 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 313
TABLE 362 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 314
TABLE 363 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 315
TABLE 364 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 316
TABLE 365 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 316
TABLE 366 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 317
TABLE 367 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 317
TABLE 368 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 318
TABLE 369 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 318
TABLE 370 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 318
TABLE 371 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 319
TABLE 372 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 319
TABLE 373 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 319
TABLE 374 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 319
TABLE 375 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 320
TABLE 376 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 320
TABLE 377 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 320
TABLE 378 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 321
TABLE 379 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 322
TABLE 380 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 323
TABLE 381 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 323
TABLE 382 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 324
TABLE 383 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 324
TABLE 384 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 324
TABLE 385 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 325
TABLE 386 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 325
TABLE 387 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 325
TABLE 388 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 326
TABLE 389 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 326
TABLE 390 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 326
TABLE 391 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 326
TABLE 392 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 327
TABLE 393 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 327
TABLE 394 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 327
TABLE 395 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 329
TABLE 396 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 329
TABLE 397 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 330
TABLE 398 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 330
TABLE 399 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 331
TABLE 400 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 331
TABLE 401 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 331
TABLE 402 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 332
TABLE 403 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 332
TABLE 404 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 332
TABLE 405 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 333
TABLE 406 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 333
TABLE 407 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 333
TABLE 408 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 334
TABLE 409 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 334
TABLE 410 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 334
TABLE 411 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 336
TABLE 412 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 336
TABLE 413 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2022–2025 (TONS) 337
TABLE 414 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2026–2031 (TONS) 337
TABLE 415 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY VITAMIN, 2022–2025 (USD MILLION) 338
TABLE 416 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY VITAMIN, 2026–2031 (USD MILLION) 338
TABLE 417 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY MINERAL, 2022–2025 (USD MILLION) 338
TABLE 418 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY MINERAL, 2026–2031 (USD MILLION) 339
TABLE 419 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY AMINO ACID, 2022–2025 (USD MILLION) 339
TABLE 420 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY AMINO ACID, 2026–2031 (USD MILLION) 339
TABLE 421 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY APPLICATION, 2022–2025 (USD MILLION) 340
TABLE 422 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY APPLICATION, 2026–2031 (USD MILLION) 340
TABLE 423 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 340
TABLE 424 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 341
TABLE 425 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 341
TABLE 426 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 341
TABLE 427 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 342
TABLE 428 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 343
TABLE 429 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2022–2025 (TONS) 343
TABLE 430 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2026–2031 (TONS) 344
TABLE 431 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 344
TABLE 432 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 345
TABLE 433 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 345
TABLE 434 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 345
TABLE 435 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 346
TABLE 436 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 346
TABLE 437 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 346
TABLE 438 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 346
TABLE 439 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET,
BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 347
TABLE 440 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET,
BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 347
TABLE 441 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET,
BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 347
TABLE 442 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET,
BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 348
TABLE 443 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 349
TABLE 444 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 349
TABLE 445 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2022–2025 (TONS) 349
TABLE 446 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2026–2031 (TONS) 350
TABLE 447 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 350
TABLE 448 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 351
TABLE 449 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 351
TABLE 450 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 352
TABLE 451 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 352
TABLE 452 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 353
TABLE 453 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 353
TABLE 454 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 353
TABLE 455 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 354
TABLE 456 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 354
TABLE 457 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE,
2022–2025 (USD MILLION) 354
TABLE 458 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE,
2026–2031 (USD MILLION) 355
TABLE 459 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 355
TABLE 460 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 355
TABLE 461 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 355
TABLE 462 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 356
TABLE 463 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 356
TABLE 464 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 356
TABLE 465 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 358
TABLE 466 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 358
TABLE 467 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 359
TABLE 468 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 359
TABLE 469 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 360
TABLE 470 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 360
TABLE 471 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 360
TABLE 472 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 361
TABLE 473 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 361
TABLE 474 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 361
TABLE 475 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 362
TABLE 476 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 362
TABLE 477 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 362
TABLE 478 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 363
TABLE 479 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 363
TABLE 480 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 363
TABLE 481 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 364
TABLE 482 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 365
TABLE 483 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 365
TABLE 484 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 366
TABLE 485 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 366
TABLE 486 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 367
TABLE 487 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 367
TABLE 488 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 367
TABLE 489 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 368
TABLE 490 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 368
TABLE 491 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 368
TABLE 492 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 368
TABLE 493 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 369
TABLE 494 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 369
TABLE 495 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 369
TABLE 496 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 370
TABLE 497 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 371
TABLE 498 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 371
TABLE 499 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2022–2025 (TONS) 372
TABLE 500 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY INGREDIENT TYPE, 2026–2031 (TONS) 372
TABLE 501 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 373
TABLE 502 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 373
TABLE 503 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 373
TABLE 504 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 374
TABLE 505 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY AMINO ACID, 2022–2025 (USD MILLION) 374
TABLE 506 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY AMINO ACID, 2026–2031 (USD MILLION) 374
TABLE 507 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY APPLICATION, 2022–2025 (USD MILLION) 375
TABLE 508 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY APPLICATION, 2026–2031 (USD MILLION) 375
TABLE 509 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 375
TABLE 510 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 376
TABLE 511 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 376
TABLE 512 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 376
TABLE 513 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 377
TABLE 514 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 377
TABLE 515 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 377
TABLE 516 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 378
TABLE 517 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 378
TABLE 518 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 379
TABLE 519 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 379
TABLE 520 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 380
TABLE 521 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 380
TABLE 522 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 381
TABLE 523 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 381
TABLE 524 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 381
TABLE 525 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 382
TABLE 526 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 382
TABLE 527 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE,
2022–2025 (USD MILLION) 382
TABLE 528 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE,
2026–2031 (USD MILLION) 383
TABLE 529 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 383
TABLE 530 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 383
TABLE 531 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 383
TABLE 532 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 384
TABLE 533 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 384
TABLE 534 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 384
TABLE 535 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 385
TABLE 536 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 386
TABLE 537 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 386
TABLE 538 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 387
TABLE 539 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 387
TABLE 540 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 388
TABLE 541 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 388
TABLE 542 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 388
TABLE 543 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 389
TABLE 544 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 389
TABLE 545 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 389
TABLE 546 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 389
TABLE 547 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 390
TABLE 548 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 390
TABLE 549 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 390
TABLE 550 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 391
TABLE 551 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (USD MILLION) 392
TABLE 552 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (USD MILLION) 392
TABLE 553 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2022–2025 (TONS) 393
TABLE 554 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE,
2026–2031 (TONS) 393
TABLE 555 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2022–2025 (USD MILLION) 394
TABLE 556 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN,
2026–2031 (USD MILLION) 394
TABLE 557 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2022–2025 (USD MILLION) 394
TABLE 558 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL,
2026–2031 (USD MILLION) 395
TABLE 559 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2022–2025 (USD MILLION) 395
TABLE 560 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID,
2026–2031 (USD MILLION) 395
TABLE 561 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 396
TABLE 562 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 396
TABLE 563 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2022–2025 (USD MILLION) 396
TABLE 564 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION,
2026–2031 (USD MILLION) 397
TABLE 565 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2022–2025 (USD MILLION) 397
TABLE 566 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION,
2026–2031 (USD MILLION) 397
TABLE 567 COMPETITIVE STRATEGIES INITIATIVES IN NUTRACEUTICAL INGREDIENTS MARKET 399
TABLE 568 NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION 406
TABLE 569 NUTRACEUTICAL INGREDIENTS MARKET: REGION FOOTPRINT 410
TABLE 570 NUTRACEUTICAL INGREDIENTS MARKET: INGREDIENT TYPE FOOTPRINT 411
TABLE 571 NUTRACEUTICAL INGREDIENTS MARKET: SOURCE FOOTPRINT 412
TABLE 572 NUTRACEUTICAL INGREDIENTS MARKET: APPLICATION FOOTPRINT 413
TABLE 573 NUTRACEUTICAL INGREDIENTS MARKET: KEY STARTUPS/SMES 416
TABLE 574 NUTRACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025 417
TABLE 575 NUTRACEUTICAL INGREDIENTS MARKET: PRODUCT LAUNCHES,
2021–AUGUST 2026 418
TABLE 576 NUTRACEUTICAL INGREDIENTS MARKET: DEALS, 2021–AUGUST 2026 420
TABLE 577 NUTRACEUTICAL INGREDIENTS MARKET: EXPANSIONS, 2021–AUGUST 2026 422
TABLE 578 CARGILL, INCORPORATED: COMPANY OVERVIEW 425
TABLE 579 CARGILL, INCORPORATED: PRODUCTS OFFERED 426
TABLE 580 CARGILL, INCORPORATED: PRODUCT LAUNCHES 429
TABLE 581 CARGILL, INCORPORATED: DEALS 430
TABLE 582 CARGILL, INCORPORATED: EXPANSIONS 431
TABLE 583 CARGILL, INCORPORATED: OTHER DEVELOPMENTS 433
TABLE 584 ADM: COMPANY OVERVIEW 435
TABLE 585 ADM: PRODUCTS OFFERED 436
TABLE 586 ADM: PRODUCT LAUNCHES 441
TABLE 587 ADM: DEALS 441
TABLE 588 ADM: EXPANSIONS 443
TABLE 589 ADM: OTHER DEVELOPMENTS 444
TABLE 590 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY OVERVIEW 447
TABLE 591 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED 448
TABLE 592 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCT LAUNCHES 451
TABLE 593 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS 453
TABLE 594 INTERNATIONAL FLAVORS & FRAGRANCES INC.: EXPANSIONS 454
TABLE 595 INTERNATIONAL FLAVORS & FRAGRANCES INC.: OTHER DEVELOPMENTS 456
TABLE 596 BASF: COMPANY OVERVIEW 458
TABLE 597 BASF: PRODUCTS OFFERED 459
TABLE 598 BASF: PRODUCT LAUNCHES 463
TABLE 599 BASF: DEALS 463
TABLE 600 BASF: EXPANSIONS 464
TABLE 601 BASF: OTHER DEVELOPMENTS 465
TABLE 602 GLANBIA PLC: COMPANY OVERVIEW 467
TABLE 603 GLANBIA PLC: PRODUCTS OFFERED 468
TABLE 604 GLANBIA PLC: PRODUCT LAUNCHES 472
TABLE 605 GLANBIA PLC: DEALS 473
TABLE 606 GLANBIA PLC: EXPANSIONS 474
TABLE 607 GLANBIA PLC: OTHER DEVELOPMENTS 475
TABLE 608 ARLA FOODS AMBA: COMPANY OVERVIEW 477
TABLE 609 ARLA FOODS AMBA: PRODUCTS OFFERED 478
TABLE 610 ARLA FOODS AMBA: PRODUCT LAUNCHES 480
TABLE 611 ARLA FOODS AMBA: DEALS 481
TABLE 612 ARLA FOODS AMBA: EXPANSIONS 483
TABLE 613 ARLA FOODS AMBA: OTHER DEVELOPMENTS 484
TABLE 614 DSM-FIRMENICH: COMPANY OVERVIEW 486
TABLE 615 DSM-FIRMENICH: PRODUCTS OFFERED 487
TABLE 616 DSM-FIRMENICH: PRODUCT LAUNCHES 494
TABLE 617 DSM-FIRMENICH: DEALS 496
TABLE 618 DSM-FIRMENICH: EXPANSIONS 497
TABLE 619 DSM-FIRMENICH: OTHER DEVELOPMENTS 499
TABLE 620 INGREDION: COMPANY OVERVIEW 501
TABLE 621 INGREDION: PRODUCTS OFFERED 502
TABLE 622 INGREDION: PRODUCT LAUNCHES 505
TABLE 623 INGREDION: DEALS 507
TABLE 624 INGREDION: EXPANSIONS 508
TABLE 625 INGREDION: OTHER DEVELOPMENTS 508
TABLE 626 TATE & LYLE: COMPANY OVERVIEW 510
TABLE 627 TATE & LYLE: PRODUCTS OFFERED 511
TABLE 628 TATE & LYLE: PRODUCT LAUNCHES 512
TABLE 629 TATE & LYLE: DEALS 513
TABLE 630 TATE & LYLE: EXPANSIONS 514
TABLE 631 TATE & LYLE: OTHER DEVELOPMENTS 515
TABLE 632 ROQUETTE FRÈRES: COMPANY OVERVIEW 516
TABLE 633 ROQUETTE FRÈRES: PRODUCTS OFFERED 517
TABLE 634 ROQUETTE FRÈRES: PRODUCT LAUNCHES 520
TABLE 635 ROQUETTE FRÈRES: DEALS 521
TABLE 636 ROQUETTE FRÈRES: EXPANSIONS 522
TABLE 637 ROQUETTE FRÈRES: OTHER DEVELOPMENTS 522
TABLE 638 ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW 524
TABLE 639 ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED 525
TABLE 640 ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES 528
TABLE 641 ASSOCIATED BRITISH FOODS PLC: DEALS 529
TABLE 642 ASSOCIATED BRITISH FOODS PLC: EXPANSIONS 530
TABLE 643 ASSOCIATED BRITISH FOODS PLC: OTHER DEVELOPMENTS 531
TABLE 644 FONTERRA CO-OPERATIVE GROUP LIMITED: COMPANY OVERVIEW 533
TABLE 645 FONTERRA CO-OPERATIVE GROUP LIMITED: PRODUCTS OFFERED 534
TABLE 646 FONTERRA CO-OPERATIVE GROUP LIMITED: PRODUCT LAUNCHES 538
TABLE 647 FONTERRA CO-OPERATIVE GROUP LIMITED: DEALS 538
TABLE 648 FONTERRA CO-OPERATIVE GROUP LIMITED: EXPANSIONS 539
TABLE 649 FONTERRA CO-OPERATIVE GROUP LIMITED: OTHER DEVELOPMENTS 540
TABLE 650 KERRY GROUP PLC: COMPANY OVERVIEW 541
TABLE 651 KERRY GROUP PLC: PRODUCTS OFFERED 542
TABLE 652 KERRY GROUP PLC: PRODUCT LAUNCHES 546
TABLE 653 KERRY GROUP PLC: DEALS 546
TABLE 654 KERRY GROUP PLC: EXPANSIONS 548
TABLE 655 KERRY GROUP PLC: OTHER DEVELOPMENTS 548
TABLE 656 NOVONESIS GROUP: COMPANY OVERVIEW 550
TABLE 657 NOVONESIS GROUP: PRODUCTS OFFERED 551
TABLE 658 NOVONESIS GROUP: PRODUCT LAUNCHES 554
TABLE 659 NOVONESIS GROUP: DEALS 555
TABLE 660 NOVONESIS GROUP: EXPANSIONS 555
TABLE 661 NOVONESIS GROUP: OTHER DEVELOPMENTS 556
TABLE 662 BALCHEM CORP.: COMPANY OVERVIEW 558
TABLE 663 BALCHEM CORP.: PRODUCTS OFFERED 559
TABLE 664 BALCHEM CORP.: PRODUCT LAUNCHES 563
TABLE 665 BALCHEM CORP.: DEALS 564
TABLE 666 BALCHEM CORP.: EXPANSIONS 565
TABLE 667 BALCHEM CORP.: OTHER DEVELOPMENTS 566
TABLE 668 AJINOMOTO CO., INC.: COMPANY OVERVIEW 568
TABLE 669 AJINOMOTO CO., INC.: PRODUCTS OFFERED 569
TABLE 670 AJINOMOTO CO., INC.: DEALS 571
TABLE 671 AJINOMOTO CO., INC.: EXPANSIONS 572
TABLE 672 AJINOMOTO CO., INC.: OTHER DEVELOPMENTS 572
TABLE 673 DIVI'S LABORATORIES LIMITED: COMPANY OVERVIEW 574
TABLE 674 DIVI'S LABORATORIES LIMITED: PRODUCTS OFFERED 575
TABLE 675 DIVI'S LABORATORIES LIMITED: DEALS 578
TABLE 676 DIVI'S LABORATORIES LIMITED: EXPANSIONS 578
TABLE 677 KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW 580
TABLE 678 KEMIN INDUSTRIES, INC.: PRODUCTS OFFERED 581
TABLE 679 KEMIN INDUSTRIES, INC.: PRODUCT LAUNCHES 582
TABLE 680 KEMIN INDUSTRIES, INC.: DEALS 583
TABLE 681 KEMIN INDUSTRIES, INC.: OTHER DEVELOPMENTS 584
TABLE 682 GELITA: COMPANY OVERVIEW 585
TABLE 683 GELITA: PRODUCTS OFFERED 585
TABLE 684 GELITA: PRODUCT LAUNCHES 587
TABLE 685 GELITA: DEALS 588
TABLE 686 GELITA: EXPANSIONS 588
TABLE 687 GELITA: OTHER DEVELOPMENTS 589
TABLE 688 BENEO: COMPANY OVERVIEW 590
TABLE 689 BENEO: PRODUCTS OFFERED 591
TABLE 690 BENEO: PRODUCT LAUNCHES 592
TABLE 691 BENEO: DEALS 593
TABLE 692 BENEO: EXPANSIONS 594
TABLE 693 BENEO: OTHER DEVELOPMENTS 595
TABLE 694 COSUCRA: COMPANY OVERVIEW 596
TABLE 695 CONAGEN, INC.: COMPANY OVERVIEW 597
TABLE 696 SARSHIKA PHARMACHEM LLP: COMPANY OVERVIEW 598
TABLE 697 CANURTA NATURALS USA: COMPANY OVERVIEW 599
TABLE 698 EVANIUM: COMPANY OVERVIEW 600
TABLE 699 ADJACENT MARKETS TO NUTRACEUTICAL INGREDIENTS MARKET 612
TABLE 700 PROTEIN INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 614
TABLE 701 PROTEIN INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 614
TABLE 702 PROTEIN INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 614
TABLE 703 PROTEIN INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 615
TABLE 704 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE,
2021–2024 (USD MILLION) 616
TABLE 705 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE,
2025–2030 (USD MILLION) 616
FIGURE 1 MARKET SEGMENTATION 48
FIGURE 2 MARKET SCENARIO 54
FIGURE 3 NUTRACEUTICAL INGREDIENTS MARKET, 2022–2031 55
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET, 2021–JUNE 2026 55
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH NUTRACEUTICAL INGREDIENTS MARKET 56
FIGURE 6 NUTRACEUTICAL INGREDIENTS MARKET: HIGH-GROWTH SEGMENTS, 2026–2031 57
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 58
FIGURE 8 GROWING DEMAND FOR TARGETED NUTRITION AND FUNCTIONAL INGREDIENTS TO DRIVE MARKET GROWTH 59
FIGURE 9 FUNCTIONAL PROTEINS SEGMENT AND ASIA PACIFIC TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026 60
FIGURE 10 PLANT-BASED SEGMENT TO LEAD MARKET IN 2026 61
FIGURE 11 FUNCTIONAL PROTEINS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE
IN 2026 62
FIGURE 12 HUMAN NUTRITION SEGMENT TO DOMINATE MARKET IN 2026 62
FIGURE 13 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 63
FIGURE 14 NUTRACEUTICAL INGREDIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
FIGURE 15 SOURCES USED TO CONSUME SELECTED NUTRIENTS 67
FIGURE 16 NUTRACEUTICAL INGREDIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 86
FIGURE 17 GLOBAL CURRENT HEALTH EXPENDITURE AS A SHARE OF GDP, 2000–2023 (%) 90
FIGURE 18 REAL HOUSEHOLD INCOME PER CAPITA GROWTH IN OECD, Q2 2023–Q2 2025 (%) 91
FIGURE 20 NUTRACEUTICAL INGREDIENTS MARKET: MARKET MAP 96
FIGURE 21 AVERAGE SELLING PRICE TREND, BY INGREDIENT TYPE, 2022-2025 (USD/KG) 98
FIGURE 22 AVERAGE SELLING PRICE TREND, BY REGION (USD/KG) 99
FIGURE 23 EXPORT VALUE OF HS CODE 2936, BY KEY COUNTRY, 2021–2025 (USD MILLION) 101
FIGURE 24 IMPORT VALUE OF HS CODE 2936, BY KEY COUNTRY, 2021–2025 (USD MILLION) 102
FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 106
FIGURE 26 INVESTMENT AND FUNDING SCENARIO, 2021–2026 (USD MILLION) 106
FIGURE 27 NUMBER OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2016–2026 134
FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2016–2026 134
FIGURE 29 FUTURE APPLICATIONS 136
FIGURE 31 KEY BUYING CRITERIA FOR APPLICATION 147
FIGURE 32 ADOPTION BARRIERS AND INTERNAL CHALLENGES 149
FIGURE 33 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026 VS. 2031 159
FIGURE 34 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026 VS. 2031 201
FIGURE 35 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2026 VS. 2031 (USD MILLION) 211
FIGURE 36 INDIA TO RECORD FASTEST GROWTH DURING FORECAST PERIOD 227
FIGURE 37 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT 230
FIGURE 38 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT 306
FIGURE 39 BRAND/PRODUCT COMPARISON 401
FIGURE 40 NUTRACEUTICAL INGREDIENTS MARKET: REVENUE ANALYSIS FOR
FIVE KEY PLAYERS, 2023–2025 (USD BILLION) 403
FIGURE 41 COMPANY VALUATION OF NUTRACEUTICAL INGREDIENTS PLAYERS 404
FIGURE 42 EV/EBITDA OF KEY COMPANIES 405
FIGURE 43 SHARE OF LEADING COMPANIES IN NUTRACEUTICAL INGREDIENTS MARKET, 2025 406
FIGURE 44 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 409
FIGURE 45 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY FOOTPRINT 410
FIGURE 46 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 415
FIGURE 47 CARGILL, INCORPORATED: COMPANY SNAPSHOT 426
FIGURE 48 ADM: COMPANY SNAPSHOT 436
FIGURE 49 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT 448
FIGURE 50 BASF: COMPANY SNAPSHOT 459
FIGURE 51 GLANBIA PLC: COMPANY SNAPSHOT 468
FIGURE 52 ARLA FOODS AMBA: COMPANY SNAPSHOT 478
FIGURE 53 DSM-FIRMENICH: COMPANY SNAPSHOT 487
FIGURE 54 INGREDION: COMPANY SNAPSHOT 502
FIGURE 55 TATE & LYLE: COMPANY SNAPSHOT 511
FIGURE 56 ROQUETTE FRÈRES: COMPANY SNAPSHOT 517
FIGURE 57 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 525
FIGURE 58 FONTERRA CO-OPERATIVE GROUP LIMITED: COMPANY SNAPSHOT 534
FIGURE 59 KERRY GROUP PLC: COMPANY SNAPSHOT 542
FIGURE 60 NOVONESIS GROUP: COMPANY SNAPSHOT 551
FIGURE 61 BALCHEM CORP.: COMPANY SNAPSHOT 559
FIGURE 62 AJINOMOTO CO., INC.: COMPANY SNAPSHOT 569
FIGURE 63 DIVI'S LABORATORIES LIMITED: COMPANY SNAPSHOT 575
FIGURE 64 NUTRACEUTICAL INGREDIENTS MARKET: RESEARCH DESIGN 601
FIGURE 65 KEY DATA FROM SECONDARY SOURCES 602
FIGURE 66 KEY DATA FROM PRIMARY SOURCES 603
FIGURE 67 INSIGHTS FROM INDUSTRY EXPERTS 604
FIGURE 68 BREAKDOWN OF PRIMARIES, BY COMPANY TYPE, DESIGNATION, AND REGION 604
FIGURE 69 NUTRACEUTICAL INGREDIENTS MARKET: BOTTOM-UP APPROACH 606
FIGURE 70 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 607
FIGURE 71 MARKET SIZE ESTIMATION METHODOLOGY: SUPPLY-SIDE ANALYSIS 608
FIGURE 72 MARKET SIZE ESTIMATION METHODOLOGY: DEMAND-SIDE ANALYSIS 609
FIGURE 73 DATA TRIANGULATION METHODOLOGY 610
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們